直播预告 | 非人灵长类动物实验中数据量与群组规模如何影响药理药效分析

直播主题：非人灵长类动物实验中数据量与群组规模如何影响药理药效分析

Topic: Size Matters in NHP Pharmacology: Data Size and Group Size

直播时间：美国东部时间7月17日12:00（北京时间 7月18日0点）

Date&Time: July17, 2025 at 12:00PM EDT

演讲嘉宾：徐德鸣博士 澎立生物疾病药理学部SVP

Speaker: Dr. Deming Xu, SVP of PharmaLegacy 

直播介绍：在药理学研究中，选择非人灵长类动物（NHP）对评估候选药物的治疗潜力有着重要意义。但和啮齿类动物研究不同，非人灵长类动物研究面临着个体差异更大、群组规模受限等挑战。因此，如何设计和分析这类实验，直接关系到能否得出有价值的结果。本次网络直播的主讲嘉宾徐德鸣博士，在动物药效药理学领域有 20 年研究经验，其负责的澎立生物团队在非人灵长类动物药理学方面积累了15 年实践经验。在本次直播会议中，徐博士将结合多个研究案例，介绍应对上述挑战的不同思路与尝试，涉及神经精神疾病、自身免疫及炎症性疾病、代谢性疾病等模型中的非人灵长类动物药效研究。此外，他还将解析包括基线数据在内的数据量对药效分析的影响，并探讨这些案例中反映出的核心问题。

The selection of non-human primates (NHP) for pharmacological studies is obvious to the evaluation of therapeutical potential of candidate drugs.  However, unlike rodents, NHP studies are challenged with the greater individual heterogeneity and the limit of group sizes.  How to design and analyze NHP experiments is essential to meaningful outcomes.  The presenter of this Webinar, Dr. Deming Xu, has worked on animal efficacy pharmacology for 20 years, and his teams at PharmaLegacy have accumulated 15 years’ experience of NHP pharmacology.  He selects several case studies to illustrate different attempts to address these challenges.  They include NHP efficacy studies in models for neuropsychiatric disorder, autoimmune and inflammatory diseases, metabolic diseases etc.  Dr. Xu will demonstrate how data size, including baseline, impacts the analysis of drug efficacy, and discuss the key themes emerging from these cases.  Mark your calendar for this insightful presentation.

您可通过扫描二维码或复制以下链接至浏览器进行报名观看。我们期待您的参与！

Don't miss this opportunity to gain practical insights into NHP pharmacology.

ZOOM报名链接：

https://zoom.us/webinar/register/WN_akmUUPK1Q_uryHmp6bmUJQ

Register now:

https://zoom.us/webinar/register/WN_akmUUPK1Q_uryHmp6bmUJQ